| 摘要 |
The invention relates to novel N-phenyl-4-(4-pyridyl)-2-pyrimidineamine derivatives of the general formula (1) wherein the sum of (m+p) together is 0, 1, 2 or 3; n and q are independently of each other 0 or 1, and the sum of (m+p+q) together is 1, 2, 3 or 4; R1 is hydrogen, halogen, alkoxy, haloalkyl, haloalkoxy or alkyl; R2 is hydrogen, C1-C6-alkyl, C1-C6-haloalkyl or C1-C6-alkoxy; R2A is hydrogen, C1-C6-alkyl, C3-C4-alkenyl or C3-C4-alkynyl; each of R3, R4, R5 and R6 is, independently of the others, hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, hydroxy-C1-C6-alkyl or C1-C6-alkoxy-C1-C6-alkyl, or the ring members CR3R4 or CR5R6 or CR2R2A are independently of each other a carbonyl group (C=O) or a group C=S; X is C=O, C=S, S=O or O=S=O; Y is O, S, C=O, CH2A, -N(R8)-, -O-N(R8)-, -N(R8)-O- or NH-; R7 is hydrogen, C1-C4-alkyl, C3-C4-alkenyl, C3-C4-alkynyl, -CH2OR8, CH2SR8, -C(O)R8, -C(O)OR8, SO2R8, SOR8 or SR8; and R8 is C1-C8-alkyl, C1-C8-alkoxyalkyl, C1-C8 haloalkyl or phenylC1-C2</hi
|
